Compare SGHT & LANV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGHT | LANV |
|---|---|---|
| Founded | 2011 | 2015 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.2M | 228.0M |
| IPO Year | 2021 | N/A |
| Metric | SGHT | LANV |
|---|---|---|
| Price | $8.30 | $1.95 |
| Analyst Decision | Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $4.93 | N/A |
| AVG Volume (30 Days) | ★ 251.7K | 40.6K |
| Earning Date | 11-06-2025 | 08-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,052,000.00 | ★ $341,783,911.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.04 | $5.06 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.03 | $1.32 |
| 52 Week High | $8.80 | $2.69 |
| Indicator | SGHT | LANV |
|---|---|---|
| Relative Strength Index (RSI) | 75.45 | 45.54 |
| Support Level | $6.56 | $1.89 |
| Resistance Level | $7.24 | $2.06 |
| Average True Range (ATR) | 0.64 | 0.16 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 83.56 | 34.29 |
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.